Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Breast Cancer Female”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Not applicableUnknownNCT03786575
What this trial is testing

Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer

Who this might be right for
Breast Neoplasm FemaleTherapeuticsMutation
Peking Union Medical College 50
Testing effectiveness (Phase 2)Looking for participantsNCT04895709
What this trial is testing

BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Who this might be right for
Cervical CancerGastric/Gastroesophageal Junction AdenocarcinomaMicrosatellite Stable Colorectal Cancer+8 more
Bristol-Myers Squibb 1,109
Early research (Phase 1)Active Not RecruitingNCT05787587
What this trial is testing

PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsBreast CancerOvarian Cancer+6 more
IDEAYA Biosciences 216
Early research (Phase 1)Study completedNCT00827177
What this trial is testing

Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 87
Testing effectiveness (Phase 2)Ended earlyNCT00040014
What this trial is testing

Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women

Who this might be right for
Breast Neoplasms
Pfizer 100
Testing effectiveness (Phase 2)Study completedNCT00248404
What this trial is testing

NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)

Who this might be right for
Tumors
Kiadis Pharma 155
Testing effectiveness (Phase 2)Study completedNCT00379015
What this trial is testing

Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 38
Testing effectiveness (Phase 2)Looking for participantsNCT06265025
What this trial is testing

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerMalignant MelanomaColorectal Cancer+3 more
GeneMedicine Co., Ltd. 125
Early research (Phase 1)Looking for participantsNCT06547840
What this trial is testing

MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha

Who this might be right for
Advanced Ovarian CancerPlatinum-resistant Ovarian CancerTriple Negative Breast Cancer (TNBC)+3 more
Epsilogen Ltd 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06183736
What this trial is testing

CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency

Who this might be right for
Advanced Solid Tumors
Convalife (Shanghai) Co., Ltd. 98
Not applicableLooking for participantsNCT04050228
What this trial is testing

Use of Quantitative Ultrasound to Guide Adaptive Chemotherapy Among Women With Breast Cancer

Who this might be right for
Breast Cancer
Sunnybrook Health Sciences Centre 240
Testing effectiveness (Phase 2)Looking for participantsNCT06819215
What this trial is testing

Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors

Who this might be right for
CancerNeoplasmsNeoplasms, Breast+8 more
Zhejiang Yangli Pharmaceutical Technology Co., Ltd. 188
Early research (Phase 1)Active Not RecruitingNCT04706962
What this trial is testing

TH1902 in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorTNBC - Triple-Negative Breast CancerHormone Receptor-positive Breast Cancer+7 more
Theratechnologies 70
Early research (Phase 1)Study completedNCT03289962
What this trial is testing

Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

Who this might be right for
MelanomaNon-Small Cell Lung CancerBladder Cancer+5 more
Genentech, Inc. 273
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Testing effectiveness (Phase 2)Ended earlyNCT04383210
What this trial is testing

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid TumorPancreatic Cancer+14 more
Elevation Oncology 54
Early research (Phase 1)Ended earlyNCT03861403
What this trial is testing

A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced Triple Negative Breast CancerAdvanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer+2 more
Leap Therapeutics, Inc. 10
Early research (Phase 1)Looking for participantsNCT03740256
What this trial is testing

Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors

Who this might be right for
Bladder CancerHead and Neck Squamous Cell CarcinomaCancer of the Salivary Gland+7 more
Baylor College of Medicine 45
Early research (Phase 1)WithdrawnNCT01386502
What this trial is testing

CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors

Who this might be right for
Breast CancerColon CancerPancreatic Cancer+2 more
National Cancer Institute (NCI)
Next Page